Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Modeling SARS-CoV-2 in mice: Among the research tools necessary to develop medical interventions to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, high on the list are informative animal models with which to study viral pathogenesis. Gu et al. developed a mouse model in which a SARS-CoV-2 strain was infectious and could cause an inflammatory response and moderate pneumonia. Adaptation of this viral strain in the mouse appeared to be dependent on a critical amino acid change, Asn 501 to Tyr (N501Y), within the receptor-binding domain of the viral spike protein. The new mouse model was used to study neutralizing antibodies and a vaccine candidate against the virus. Science , this issue p. 1603
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although mouse models have the most information available about their biology and many research tools, the ACE2 receptor is significantly different between mice and humans; so mouse models most often use a humanized ACE2 or lung passage to overcome this obstacle. 177-179”
From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [179]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Self-citationA novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Self-citationA pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Self-citationDipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
Raj, V. S., Mou, H., Smits, S. L., Dekkers, D. H. W., Müller, M. A., Dijkman, R., Muth, D., Demmers, J. A. A., Zaki, A., Fouchier, R. A. M., et al. (2013) · Nature · doi:10.1038/nature12005 · Cited by 2,061
Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2
Shi, J., Wen, Z., Zhong, G., Yang, H., Wang, C., Huang, B., Liu, R., He, X., Shuai, L., Sun, Z., et al. (2020) · Science · doi:10.1126/science.abb7015 · Cited by 1,911
The spike protein of SARS-CoV — a target for vaccine and therapeutic development
Du, L., He, Y., Zhou, Y., Liu, S., Zheng, B.-J., & Jiang, S. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2090 · Cited by 1,661
Self-citationTai, W., He, L., Zhang, X., Pu, J., Voronin, D., Jiang, S., Zhou, Y., & Du, L. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0400-4 · Cited by 1,654
Self-citationImmunology of COVID-19: Current State of the Science
Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623
Self-citationDevelopment of an inactivated vaccine candidate for SARS-CoV-2
Gao, Q., Bao, L., Mao, H., Wang, L., Xu, K., Yang, M., Li, Y., Zhu, L., Wang, N., Lv, Z., et al. (2020) · Science · doi:10.1126/science.abc1932 · Cited by 1,434
Self-citationCarsana, L., Sonzogni, A., Nasr, A., Rossi, R. S., Pellegrinelli, A., Zerbi, P., Rech, R., Colombo, R., Antinori, S., Corbellino, M., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30434-5 · Cited by 1,396
Cited by
Items 401–500 of 786
Convergent evolution of SARS-CoV-2 in human and animals
Zhou, H., Ji, C., Fan, H., Han, N., Li, X., Wu, A., & Qin, C. (2021) · Protein & Cell · doi:10.1007/s13238-021-00847-6 · Cited by 17
Self-citationMerkuleva, I. A., Щербаков, Д. Н., Borgoyakova, M. B., Исаева, А. А., Nesmeyanova, V. S., Волкова, Н. В., Aripov, V. S., Васильевич, Ш. Д., Карпенко, Л. И., Belenkaya, S. V., et al. (2022) · Viruses · doi:10.3390/v14051060 · Cited by 18
Structural basis of SARS-CoV-2 and its variants binding to intermediate horseshoe bat ACE2
Tang, L., Zhang, D., Han, P., Kang, X., Zheng, A., Xu, Z., Zhao, X., Wang, V. Y., Qi, J., Wang, Q., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.73640 · Cited by 16
Hiscox, J. A., Khoo, S., Stewart, J. P., & Owen, A. (2021) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkab189 · Cited by 16
Zhang, X., Hong, B., Wei, P., Pei, P., Xu, H. C., Chen, L., Tong, Y., Chen, J., Luo, S., Fan, H., et al. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2128887 · Cited by 16
Self-citationChen, Y., Song, W., Li, C., Wang, J., Liu, F., Ye, Z., Ren, P., Tong, Y., Li, J., Ou, Z., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104485 · Cited by 18
Self-citationKalyoncu, S., Yılmaz, S., Kuyucu, A. Z., Sayili, D., Mert, O., Soytürk, H., Gullu, S., Akinturk, H., Çıtak, E., Arslan, M., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-32021-9 · Cited by 16
Wang, S., Zhang, C., Liang, B., Wang, W., Feng, N., Zhao, Y., Wang, T., Guo, Z., Yan, F., Yang, S., et al. (2022) · Viruses · doi:10.3390/v14061127 · Cited by 16
Wang, X., Zhang, M., He, N., Wang, Y., Yan, C., Chen, X., Gao, X.-F., Guo, J., Luo, R., & Liu, Z. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00881 · Cited by 16
Self-citationCharacterization of SARS-CoV-2 Variants N501Y.V1 and N501Y.V2 Spike on Viral Infectivity
Tang, H., Gao, L., Wu, Z., Meng, F., Zhao, X., Shao, Y., Shi, X., Qiao, S., An, J., Du, X., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.720357 · Cited by 15
Fujita, S., Kosugi, Y., Kimura, I., Tokunaga, K., Ito, J., Sato, K., Matsuno, K., Nao, N., Sawa, H., Tanaka, S., et al. (2023) · Journal of Virology · doi:10.1128/jvi.00990-23 · Cited by 16
Identification of FasL as a crucial host factor driving COVID-19 pathology and lethality
Albert, M., Uranga-Murillo, I., Arias, M. A., de Miguel, D., Peña, N., Montinaro, A., Varanda, A. B., Theobald, S. J., Zubiaur, I. A., Saggau, J., et al. (2024) · Cell Death and Differentiation · doi:10.1038/s41418-024-01278-6 · Cited by 15
Mendoza‐Ramírez, N. J., García‐Cordero, J., Shrivastava, G., & Cedillo‐Barrón, L. (2024) · Journal of Immunology Research · doi:10.1155/2024/9313267 · Cited by 19
Liang, R., Liu, K., Li, Y., Zhang, X., Duan, L., Huang, M., Sun, L., Yuan, F., Zhao, J., Zhao, Y., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012415 · Cited by 15
Self-citationLiu, T., Li, J., Yin, X., Lu, F., Zhao, H. J., Wang, L., & Qin, C. (2024) · Gut · doi:10.1136/gutjnl-2024-332784 · Cited by 15
Self-citationMAIT Cells in COVID-19: Heroes, Villains, or Both?
Haeryfar, S. M. M. (2020) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2020034943 · Cited by 18
López-Cortés, G. I., Palacios-Pérez, M., Zamudio, G. S., Veledíaz, H. F., Ortega, E., & José, M. V. (2021) · Scientific Reports · doi:10.1038/s41598-021-96950-z · Cited by 15
Li, Z., & Zhang, J. Z. H. (2021) · Physical Chemistry Chemical Physics · doi:10.1039/d1cp01075a · Cited by 15
mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2
Darling, T. L., Ying, B., Whitener, B. M., VanBlargan, L. A., Bricker, T. L., Liang, C.-Y., Joshi, A., Bamunuarachchi, G., Seehra, K., Schmitz, A. J., et al. (2022) · Med · doi:10.1016/j.medj.2022.03.009 · Cited by 15
A SCID Mouse Model To Evaluate the Efficacy of Antivirals against SARS-CoV-2 Infection
Abdelnabi, R., Foo, C. S.-Y., Kaptein, S. J. F., Boudewijns, R., Vangeel, L., Jonghe, S. D., Jochmans, D., Weynand, B., & Neyts, J. H. (2022) · Journal of Virology · doi:10.1128/jvi.00758-22 · Cited by 16
Further information on possible animal sources for human COVID‐19
Opriessnig, T., & Huang, Y. (2020) · Xenotransplantation · doi:10.1111/xen.12651 · Cited by 16
Ma, C., & Gong, C. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26953 · Cited by 14
Impact of age and sex on neuroinflammation following SARS-CoV-2 infection in a murine model
Krishna, V. D., Chang, A., Korthas, H. T., Var, S. R., Seelig, D. M., Low, W. C., Li, L., & Cheeran, M. C. ‐. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1404312 · Cited by 15
SIRT2 suppresses aging-associated cGAS activation and protects aged mice from severe COVID-19
Barthez, M., Xue, B., Zheng, J., Wang, Y., Song, Z., Mu, W., Wang, C.-L., Guo, J., Yang, F., Ma, Y., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115562 · Cited by 16
Self-citationAre the emerging SARS-COV-2 mutations friend or foe?
Erol, A. (2021) · Immunology Letters · doi:10.1016/j.imlet.2020.12.014 · Cited by 14
Su, S., Wang, Q., & Jiang, S. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.284 · Cited by 15
Self-citationChen, H., Kang, Y. M., Duan, M., & Hou, T. (2021) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.1c01548 · Cited by 14
Liu, J., Chen, Q., Yang, S., Li, Y., Dou, Y., Deng, Y., Bi, J., Tan, Y., Hongfan, W., Gong, W., et al. (2021) · Cell Discovery · doi:10.1038/s41421-021-00293-y · Cited by 14
Self-citationFranceschi, V. B., Caldana, G. D., Perin, C., Horn, A., Peter, C., Cybis, G. B., Ferrareze, P. A. G., Rotta, L. N., Cadegiani, F., Zimerman, R. A., et al. (2021) · Pathogens · doi:10.3390/pathogens10080988 · Cited by 16
A comprehensive review of the analysis and integration of omics data for SARS-CoV-2 and COVID-19
Zhu, Z., Zhang, S., Wang, P., Chen, X., Bi, J., Cheng, L., & Zhang, X. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab446 · Cited by 14
COVID-19 Risk Assessment for the Tokyo Olympic Games
Zhu, W., Feng, J., Li, C., Wang, H., Zhong, Y., Zhou, L. J., Zhang, X., & Zhang, T. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.730611 · Cited by 14
Self-citationLi, Y., & Li, J. Z. (2022) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2022.01.004 · Cited by 17
Self-citationTransmissibility and pathogenicity of SARS-CoV-2 variants in animal models
Kim, Y., Casel, M. A. B., & Choi, Y. K. (2022) · The Journal of Microbiology · doi:10.1007/s12275-022-2033-z · Cited by 15
Evolutionary dynamics of the severe acute respiratory syndrome coronavirus 2 genomes
Qian, Z., Li, P., Tang, X., & Lü, J. (2022) · Medical Review · doi:10.1515/mr-2021-0035 · Cited by 14
3D Bioprinted Neural‐Like Tissue as a Platform to Study Neurotropism of Mouse‐Adapted SARS‐CoV‐2
de Melo, B. A. G., Mundim, M. V., Lemes, R. M. R., Cruz, E. M., Ribeiro, T. N., Santiago, C. F., da Fonsêca, J. H. L., Benincasa, J. C., Stilhano, R. S., Mantovani, N., et al. (2022) · Advanced Biology · doi:10.1002/adbi.202200002 · Cited by 15
Clinical and genomic signatures of SARS-CoV-2 Delta breakthrough infections in New York
Duerr, R., Dimartino, D., Marier, C., Zappile, P., Levine, S., François, F., Iturrate, E., Wang, G., Dittmann, M., Lighter, J., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104141 · Cited by 15
Characteristics of animal models for COVID‐19
Qi, F., & Qin, C. (2022) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12278 · Cited by 15
Self-citationRisk assessment of SARS‐CoV‐2 infection in free‐ranging wild animals in Belgium
Logeot, M., Mauroy, A., Thiry, É., Regge, N. D., Vervaeke, M., Beck, O., Waele, V. D., & van den Berg, T. (2021) · Transboundary and Emerging Diseases · doi:10.1111/tbed.14131 · Cited by 16
Kuiper, M. J., Wilson, L. O. W., Mangalaganesh, S., Lee, C., Reti, D., & Vasan, S. S. (2021) · ILAR Journal · doi:10.1093/ilar/ilab031 · Cited by 14
Ji, C., Xue, S., Yu, M., Liu, J., Zhang, Q., Zuo, F., Zheng, Q., Zhao, L., Zhang, H., Cao, J., et al. (2021) · ACS Omega · doi:10.1021/acsomega.0c05781 · Cited by 13
Xiong, Q., Ma, C., Liu, C., Tong, F., Huang, M., & Yan, H. (2024) · Cell Insight · doi:10.1016/j.cellin.2023.100145 · Cited by 15
Kirk, N. M., Liang, Y., & Ly, H. (2024) · Virulence · doi:10.1080/21505594.2024.2316438 · Cited by 15
Marsh, G. A., McAuley, A. J., Brown, S., Pharo, E. A., Crameri, S. G., Au, G. G., Baker, M. L., Barr, J. A., Bergfeld, J., Bruce, M. P., et al. (2021) · Transboundary and Emerging Diseases · doi:10.1111/tbed.13978 · Cited by 15
Rational optimization of a human neutralizing antibody of SARS-CoV-2
Chen, J., Wu, F., Dan, L., Kong, W., Cai, X., Yang, J., Sun, X., & Cao, P. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104550 · Cited by 13
Animal Transmission of SARS-CoV-2 and the Welfare of Animals during the COVID-19 Pandemic
Ekstrand, K., Flanagan, A. J., Lin, I. E., Vejseli, B., Cole, A., Lally, A. P., Morris, R. L., & Morgan, K. N. (2021) · Animals · doi:10.3390/ani11072044 · Cited by 13
Animal Models to Test SARS-CoV-2 Vaccines: Which Ones Are in Use and Future Expectations
Lima, G. G., Portilho, A. I., & Gaspari, E. D. (2022) · Pathogens · doi:10.3390/pathogens12010020 · Cited by 14
Evolution of Sequence and Structure of SARS-CoV-2 Spike Protein: A Dynamic Perspective
Sinha, A., Sangeet, S., & Roy, S. (2023) · ACS Omega · doi:10.1021/acsomega.3c00944 · Cited by 15
Mouse Adapted SARS-CoV-2 Model Induces “Long-COVID” Neuropathology in BALB/c MicePreprint
Gressett, T. E., Leist, S. R., Ismael, S., Talkington, G. M., Dinnon, K. H., Baric, R. S., & Bix, G. J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.18.533204 · Cited by 16
Emergence of SARS and COVID-19 and preparedness for the next emerging disease X
Hu, B., Guo, H., Si, H.-R., & Shi, Z. (2024) · Frontiers of Medicine · doi:10.1007/s11684-024-1066-6 · Cited by 12
Sirakov, I. N., Rusenova, N., Rusenov, A. G., Gergova, R. T., & Strateva, T. (2023) · Veterinary Sciences · doi:10.3390/vetsci10010042 · Cited by 12
Risk assessment of SARS-CoV-2 replicating and evolving in animals
Zhao, J., Kang, M., Wu, H., Sun, B., Baele, G., He, W., Lu, M., Suchard, M. A., Ji, X., He, N., et al. (2023) · Trends in Microbiology · doi:10.1016/j.tim.2023.07.002 · Cited by 13
The Key Site Variation and Immune Challenges in SARS-CoV-2 Evolution
Liu, Y., & Ye, Q. (2023) · Vaccines · doi:10.3390/vaccines11091472 · Cited by 12
Necroptosis does not drive disease pathogenesis in a mouse infective model of SARS-CoV-2 in vivo
Bader, S. M., Cooney, J. P., Bhandari, R., Mackiewicz, L., Dayton, M., Sheerin, D., Georgy, S. R., Murphy, J. M., Davidson, K. C., Allison, C. C., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06471-6 · Cited by 13
Willett, J., Gravel, A., Dubuc, I., Gudimard, L., Andrade, A. C. D. S. P., Lacasse, É., Fortin, P. R., Liu, J., Cervantes, J. A., Gálvez, J. H., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-05878-3 · Cited by 13
Self-citationStebbings, R., Jones, C., Cotton, P., Armour, G., Maguire, S., Skellett, V., Tang, C.-M., Goodman, J., Brady, T. M., Takahashi, V., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.836492 · Cited by 12
Ghoula, M., Kongmeneck, A. D., Eid, R., Camproux, A., & Moroy, G. (2023) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.3c01467 · Cited by 12
SARS-CoV-2 Portrayed against HIV: Contrary Viral Strategies in Similar Disguise
Duerr, R., Crosse, K. M., Valero-Jimenez, A. M., & Dittmann, M. (2021) · Microorganisms · doi:10.3390/microorganisms9071389 · Cited by 13
Review: Development of SARS-CoV-2 immuno-enhanced COVID-19 vaccines with nano-platform
Sa-nguanmoo, N., Namdee, K., Khongkow, M., Ruktanonchai, U., Zhao, Y., & Liang, X. (2021) · Nano Research · doi:10.1007/s12274-021-3832-y · Cited by 13
Lam, S. D., Bordin, N., Waman, V., Scholes, H. M., Ashford, P., Sen, N., van Dorp, L., Rauer, C., Dawson, N. L., Pang, C., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.01.072371 · Cited by 16
Zhu, X., Mannar, D., Srivastava, S. S., Berezuk, A., Demers, J.-P., Saville, J. W., Leopold, K., Li, W., Dimitrov, D. S., Tuttle, K. S., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.11.426269 · Cited by 12
Recurrent independent emergence and transmission of SARS-CoV-2 Spike amino acid H69/V70 deletionsPreprint
Gupta, R. K., Kemp, S. A., Harvey, W. T., Lytras, S., Carabelli, A. M., & Robertson, D. L. (2021) · Research Square · doi:10.21203/rs.3.rs-136937/v1 · Cited by 12
Qu, X., Jia, Y., Jia, N., Fan, H., Zheng, A., Xia, L., Wang, Z., Tian, D., Niu, S., Hu, Y., et al. (2023) · hLife · doi:10.1016/j.hlife.2023.07.001 · Cited by 11
Self-citationChemokine receptors in COVID-19 infection
Gutierrez-Chavez, C., Aperrigue-Lira, S., Ortiz-Saavedra, B., & Paz, I. (2024) · International review of cytology · doi:10.1016/bs.ircmb.2024.05.002 · Cited by 11
CXCL12 ameliorates neutrophilia and disease severity in SARS-CoV-2 infection
Zheng, J. H., Dhakal, H., Qing, E., Shrestha, R., Geller, A. E., Morrissey, S. M., Saxena, D., Hu, X., Li, H., Li, H., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci188222 · Cited by 13
Anti-COVID-19 drug screening: Frontier concepts and core technologies
Luo, H., Zhao, M., Tan, D., Liu, C., Yang, L., Qiu, L., Gao, Y., & Yu, H. (2020) · Chinese Medicine · doi:10.1186/s13020-020-00393-z · Cited by 11
Kang, Y.-W., Park, S., Lee, K.-J., Moon, D., Kim, Y., & Lee, S. (2021) · Immune Network · doi:10.4110/in.2021.21.e1 · Cited by 11
Environmental Determinants of Coronavirus Disease 2019 (COVID-19)
Brandt, E. B., & Baye, T. M. (2021) · Current Allergy and Asthma Reports · doi:10.1007/s11882-021-00993-1 · Cited by 13
Impact of Ribosome Activity on SARS-CoV-2 LNP – Based mRNA Vaccines
Tsiambas, E., Chrysovergis, A., PAPANIKOLAOU, V. S., MASTRONIKOLIS, N. S., Ragos, V., Batistatou, A. K., Peschos, D., Kavantzas, N., Lazaris, A. C., & Kyrodimos, E. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.654866 · Cited by 12
Success of nano-vaccines against COVID-19: a transformation in nanomedicine
Sarangi, M. K., Padhi, S. K., Rath, G., Nanda, S. S., & Yi, D. K. (2022) · Expert Review of Vaccines · doi:10.1080/14760584.2022.2148659 · Cited by 13
Lu, S., Luo, S., Liu, C., Li, M., An, X., Li, M., Hou, J. W., Fan, H., Mao, P., Tong, Y., et al. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2151383 · Cited by 11
Self-citationWu, X., Fang, N., Liang, Z., Nie, J., Lang, S., Fan, C., Liang, C., Huang, W., & Wang, Y. (2023) · Vaccines · doi:10.3390/vaccines11071133 · Cited by 11
Self-citationThe COVID-19 Vaccine Landscape
Koch, T., Fathi, A., & Addo, M. M. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-63761-3_31 · Cited by 16
Tan, E., Frew, E., Cooper, J., Humphrey, J., Holden, M. T. G., Mand, A. R., Li, J., Anderson, S., Bi, M., Hatler, J. M., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11071190 · Cited by 11
Self-citationUsing in vivo animal models for studying SARS-CoV-2
da Costa, C. B. P., Cruz, A. C. D. M., Penha, J. C. Q., Castro, H. C., da Cunha, L. E. R., Ratcliffe, N. A., Cisne, R., & Martins, F. J. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2022.1995352 · Cited by 11
Severe Clinical Worsening in COVID-19 and Potential Mechanisms of Immune-Enhanced Disease
Hussman, J. P. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.637642 · Cited by 13
Qin, S., Li, R., Zheng, Z., Zeng, X., Wang, Y., & Wang, X. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27718 · Cited by 12
Self-citationA mouse-adapted SARS-CoV-2 strain replicating in standard laboratory micePreprint
Montagutelli, X., Prot, M., Jouvion, G., Levillayer, L., Conquet, L., Reyes‐Gomez, E., Donati, F., Albert, M., van der Werf, S., Jaubert, J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.10.451880 · Cited by 12
Apaa, T., Withers, A. J., MacKenzie, L., Staley, C. E., Dessi, N. C., Blanchard, A. M., Bennett, M., Bremner‐Harrison, S., Chadwick, E. A., Hailer, F., et al. (2023) · Journal of General Virology · doi:10.1099/jgv.0.001917 · Cited by 10
GB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2
Tsai, M., Yang, Y., Lin, Y., Chang, G., Hsu, C., Yeh, R., Shu, L., Cheng, Y., Liu, H.-T., Wu, Y.-H., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112011 · Cited by 10
Glocker, M. O., Opuni, K. F. M., & Thiesen, H. (2022) · Medicina · doi:10.3390/medicina58020226 · Cited by 10
Potential inhibitor for blocking binding between ACE2 and SARS-CoV-2 spike protein with mutations
Tsai, M., Shih, W., Yang, Y., Lin, Y., Chang, G., Hsu, C., Yeh, R., Shu, L., Cheng, Y., Liu, H.-T., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112802 · Cited by 10
Zhang, L., Li, Q., Wu, J., Yu, Y., Zhang, Y., Nie, J., Liang, Z., Cui, Z., Liu, S., Wang, H., et al. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2054369 · Cited by 10
Self-citationThe basis of mink susceptibility to SARS-CoV-2 infection
Barua, A., Grot, N., & Pławski, A. (2022) · Journal of Applied Genetics · doi:10.1007/s13353-022-00689-w · Cited by 10
Fukao, K., Nobori, H., Kuroda, T., Baba, K., Matsumoto, K., Tanaka, Y., Tachibana, Y., Kato, T., & Shishido, T. (2023) · Viruses · doi:10.3390/v15102052 · Cited by 10
Neuropsychiatric sequelae in an experimental model of post-COVID syndrome in mice
Pimenta, J. C., Beltrami, V. A., Oliveira, B. D. S., Queiroz‐Junior, C. M., Barsalini, J., Teixeira, D. C., Souza‐Costa, L. P., Lima, A. L. D., Machado, C. A., Parreira, B. Z. S. G., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.03.022 · Cited by 10
Stojanov, D. (2021) · Meta Gene · doi:10.1016/j.mgene.2021.100967 · Cited by 10
Hou, X.-D., Zhang, Z., Gao, J., & Wang, Y. (2021) · Molecular Systems Design & Engineering · doi:10.1039/d1me00086a · Cited by 10
Self-citationUnderstanding COVID-19: From Dysregulated Immunity to Vaccination Status Quo
Escobedo, R. A., Singh, D. K., & Kaushal, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.765349 · Cited by 11
Rodriguez, J. A., Gonzalez, J., Arboleda-Bustos, C. E., Mendoza, N., Martinez, C., & Pinzón, A. M. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110244 · Cited by 11
Structural basis of severe acute respiratory syndrome coronavirus 2 infection
Ge, J., Zhang, S., Zhang, L., & Wang, X. (2020) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000658 · Cited by 12
Self-citationMurugan, N. A., Javali, P. S., Pandian, C. J., Ali, M. A., Srivastava, V., & Jeyaraman, J. (2022) · Physical Chemistry Chemical Physics · doi:10.1039/d2cp00469k · Cited by 10
Rapid expansion of SARS-CoV-2 variants of concern is a result of adaptive epistasisPreprint
Garvin, M. R., Prates, E. T., Romero, J., Cliff, A., Gazolla, J. G. F. M., Pickholz, M., Pavicic, M., & Jacobson, D. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.03.454981 · Cited by 10
Falach, R., Bar‐On, L., Lazar, S., Kadar, T., Mazor, O., Aftalion, M., Gur, D., Evgy, Y., Shifman, O., Aminov, T., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.145916 · Cited by 9
Lam, B. K., Kung, Y. J., Lin, J. W., Tseng, S.-H., Tsai, Y. C., He, L., Castiglione, G. M., Egbert, E. R., Duh, E. J., Bloch, E. M., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109838 · Cited by 9
Self-citationProtective Immunity against Gamma and Zeta Variants after Inactivated SARS-CoV-2 Virus Immunization
Fumagalli, M. J., de Castro-Jorge, L. A., Fraga‐Silva, T. F. D. C., de Azevedo, P. O., Capato, C. F., Rattis, B. A. D. C., Hojo-Souza, N. S., Floriano, V. G., de Castro, J. T., Ramos, S. G., et al. (2021) · Viruses · doi:10.3390/v13122440 · Cited by 9
Zhu, Y., Zhou, W., Niu, Z., Sun, J., Zhang, Z., Li, Q., Zheng, Y. Y., Wang, C., Gao, L., & Sun, Q. (2022) · Biology Direct · doi:10.1186/s13062-022-00325-x · Cited by 9
Siddqui, G., Vishwakarma, P., Saxena, S., Kumar, V., Bajpai, S., Kumar, A., Kumar, S., Khatri, R., Kaur, J., Bhattacharya, S., et al. (2024) · Virus Research · doi:10.1016/j.virusres.2024.199331 · Cited by 10
Collins, C. P., Longo, D. L., & Murphy, W. J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1345499 · Cited by 9
Ding, Z., Chen, T., Lan, J., & Wong, G. (2022) · Biosafety and Health · doi:10.1016/j.bsheal.2022.05.001 · Cited by 9
Animal models for studying coronavirus infections and developing antiviral agents and vaccines
Lin, Q., Lu, C., Hong, Y., Li, R., Chen, J., Chen, W., & Chen, J. (2022) · Antiviral Research · doi:10.1016/j.antiviral.2022.105345 · Cited by 11
Metadata
- Authors
- Gu, H., Chen, Q., Yang, G., He, L., Fan, H., Deng, Y.-Q., Wang, Y., Teng, Y., Zhao, Z., Cui, Y., Li, Y., Li, X.-F., Li, J., Zhang, N.-N., Yang, X., Chen, S., Guo, Y., Zhao, G., Wang, X., Luo, D.-Y., Wang, H., Yang, X., Li, Y., Han, G., He, Y., Zhou, X., Geng, S., Sheng, X., Jiang, S., Sun, S., Qin, C.-F., & Zhou, Y.
- Affiliations
- Academy of Military Medical Sciences (CN)
- Beijing Proteome Research Center (CN)
- State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China.
- Institute of Military Cognition and Brain Sciences, Beijing 100850, China.
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Beijing JOINN Biologics Co., Beijing 100176, China.
- Shanghai Medical College of Fudan University (CN)
- Corresponding author
- Gu, Hongjing
- Chen, Qi
- Yang, Guan
- He, Lei
- Fan, Hang
- Deng, Yong-Qiang
- Jiang, Shibo
- Sun, Shihui
- Qin, Cheng-Feng
- Zhou, Yusen
- ORCID
- Gu, Hongjing
- Chen, Qi
- Yang, Guan
- He, Lei
- Fan, Hang
- Deng, Yong-Qiang
- Wang, Yanxiao
- Teng, Yue
- Zhao, Zhongpeng
- Cui, Yujun
- Li, Yuchang
- Li, Xiao-Feng
- Li, Jiangfan
- Zhang, Na-Na
- Yang, Xiaolan
- Chen, Shaolong
- Guo, Yan
- Zhao, Guangyu
- Wang, Xiliang
- Wang, Hui
- Yang, Xiao
- Li, Yan
- Han, Gencheng
- He, Yuxian
- Zhou, Xiaojun
- Jiang, Shibo
- Sun, Shihui
- Qin, Cheng-Feng
- Zhou, Yusen
- Venue
- Science
- Published
- 2020-09-25
- Volume
- 369
- Issue
- 6511
- Pages
- 1603-1607
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC7574913
- OpenAlex
- W3045870925
- Cited by
- 762
- References
- 30
- Citations by year
- 2026: 20 · 2025: 36 · 2024: 66 · 2023: 82 · 2022: 194 · 2021: 321 · 2020: 42
- FWCI
- 21.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Science (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (82041006, 82041025)
- National Science Fund for Distinguished Young Scholars (81925025)
- National Science and Technology Major Project of China (2018ZX09711003, 2017ZX10304402)
- Beijing Municipal Science and Technology Project (201100001020004)
- National Key Plan for Scientific Research and Development of China (2016YFD0500304, 2016YFD0500306, 2020YFA0707801)
- Innovation Fund for Medical Sciences of the Chinese Academy of Medical Sciences. (2019-I2M-5-049)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS-CoV-2, BALB/c mice, vaccine efficacy, serial passage, N501Y mutation, spike protein receptor-binding domain, interstitial lung disease, aged mice, challenge model, adaptive mutation, viral virulence
- MeSH terms
- Immunogenicity, Vaccine, Betacoronavirus, Angiotensin-Converting Enzyme 2, COVID-19, SARS-CoV-2, COVID-19 Vaccines, Administration, Intranasal, Animals, Disease Models, Animal, Female, Humans, Peptidyl-Dipeptidase A, Lung, Mice, Inbred BALB C, Mice, Transgenic, Mutation, Pneumonia, Viral, Vaccines, Synthetic, Viral Vaccines, Virulence, Lung Diseases, Interstitial, Coronavirus Infections, Mice, Pandemics, High-Throughput Nucleotide Sequencing, Spike Glycoprotein, Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.